Could an NLRP3 inhibitor be the one drug to conquer common diseases?
Chemical and Engineering News: Tsan Sam Xiao, associate professor in the Department of Pathology in the School of Medicine, speaks about the divide between commercial and academic arenas in the screening of proprietary chemicals.